← Eichor
Study identifier: NCT07731126 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

New Care Pathways for Supporting TRANSitional CARE From Hospital to Home Using AI and Personalized Digital Assistance

Condition: Transitional Care · Remote Patient Monitoring (RPM) · Geriatric Multimorbidity  ·  Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani

PhaseNA
Planned participants210
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

The objective of the TRANSCARE study is to evaluate the use of a digital remote monitoring system to reduce the risk of 30-day readmission in multimorbid elderly patients. The pilot study is multicenter, and the trial will be conducted across 3 sites: Italy, Romania, and Norway. The overall goal of the TRANSCARE project is to create a digital monitoring ecosystem capable of identifying and preventing the risk of readmission. Two hundred and ten older adults aged over 65, who meet the inclusion and exclusion criteria, will be enrolled in the study. They will be randomized into two groups and allocated to an intervention group or a control group.

This description comes directly from the study's public registry record.

Talk to the study team

Anna Rita Bonfigli, PhD  ·  0718003719  ·  a.bonfigli@inrca.it

Always discuss trial participation with your own doctor first.

Locations (3)

IRCCS INRCA HospitalAncona, ItalyRecruiting
Farsund KommuneFarsund, NorwayRecruiting
Institutul Inimii "Niculae Stăncioiu"Cluj-Napoca, RomaniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07731126